Brian Titus Sells 8,311 Shares of Corteva (NYSE:CTVA) Stock

Corteva, Inc. (NYSE:CTVA) insider Brian Titus sold 8,311 shares of the company’s stock in a transaction dated Friday, February 20th. The shares were sold at an average price of $76.55, for a total transaction of $636,207.05. Following the transaction, the insider owned 8,090 shares in the company, valued at $619,289.50. This represents a 50.67% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website.

Corteva Stock Down 0.3%

CTVA opened at $77.70 on Thursday. The stock has a market capitalization of $52.25 billion, a price-to-earnings ratio of 49.18, a PEG ratio of 2.66 and a beta of 0.75. The firm has a 50 day moving average price of $71.40 and a 200-day moving average price of $68.71. Corteva, Inc. has a twelve month low of $53.40 and a twelve month high of $78.59. The company has a quick ratio of 0.96, a current ratio of 1.43 and a debt-to-equity ratio of 0.07.

Corteva (NYSE:CTVA) last issued its earnings results on Tuesday, February 3rd. The company reported $0.22 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.22. The company had revenue of $3.91 billion for the quarter, compared to analysts’ expectations of $4.23 billion. Corteva had a net margin of 6.29% and a return on equity of 9.06%. The firm’s quarterly revenue was down 1.7% on a year-over-year basis. During the same quarter last year, the company posted $0.32 earnings per share. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Equities research analysts forecast that Corteva, Inc. will post 2.96 earnings per share for the current year.

Corteva Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, March 16th. Investors of record on Monday, March 2nd will be issued a $0.18 dividend. The ex-dividend date of this dividend is Monday, March 2nd. This represents a $0.72 annualized dividend and a dividend yield of 0.9%. Corteva’s payout ratio is presently 45.57%.

Wall Street Analyst Weigh In

CTVA has been the topic of several research reports. Royal Bank Of Canada raised their target price on Corteva from $80.00 to $89.00 and gave the stock an “outperform” rating in a research report on Thursday, February 5th. Citigroup increased their price objective on shares of Corteva from $74.00 to $80.00 and gave the stock a “neutral” rating in a research note on Thursday, February 5th. Weiss Ratings reissued a “hold (c-)” rating on shares of Corteva in a report on Monday, December 29th. UBS Group lowered shares of Corteva from a “buy” rating to a “hold” rating in a research report on Monday, February 9th. Finally, The Goldman Sachs Group reaffirmed a “buy” rating and set a $88.00 target price on shares of Corteva in a report on Thursday, February 5th. One equities research analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating and eight have assigned a Hold rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $82.30.

Institutional Investors Weigh In On Corteva

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Activest Wealth Management lifted its holdings in Corteva by 118.3% during the third quarter. Activest Wealth Management now owns 369 shares of the company’s stock valued at $25,000 after purchasing an additional 200 shares in the last quarter. JPL Wealth Management LLC purchased a new stake in shares of Corteva in the third quarter worth $25,000. True Wealth Design LLC raised its position in shares of Corteva by 209.5% during the 3rd quarter. True Wealth Design LLC now owns 390 shares of the company’s stock valued at $26,000 after purchasing an additional 264 shares during the period. Total Investment Management Inc. purchased a new position in shares of Corteva during the 2nd quarter valued at $27,000. Finally, Garton & Associates Financial Advisors LLC bought a new position in Corteva in the 4th quarter worth $27,000. 81.54% of the stock is owned by hedge funds and other institutional investors.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.